Introduction
Failure to undergo apoptosis is one of the mechanisms of oncogenesis and/or chemoresistance of transformed cells. Recent evidence indicates that (one of) the critical event(s) of cell death is the permeabilization of mitochondrial membranes (Green and Reed, 1998; Kroemer et al., 1998) . Permeabilization of the outer membrane is complete, culminating in the release of intermembrane proteins such as the caspase coactivator cytochrome c (Kluck et al., 1997; Liu et al., 1996; Yang et al., 1997) , pro-caspases 2, 3 and 9 (Mancini et al., 1998; Susin et al., 1999b) , or the apoptosis-inducing factor (AIF) (Susin et al., , 1999c Zamzami et al., 1996) . It either involves the (perhaps transient) physical disruption of the outer membrane (vander Heiden et al., 1997) or the formation of a non-speci®c protein-permeable pore (Kluck et al., 1997; Shimizu et al., 1999; Yang et al., 1997) . In contrast, permeabilization of the inner membrane is partial, implying free diusion of solutes up to 1500 Da, yet retention of soluble matrix proteins (Green and Reed, 1998; Kroemer et al., 1998) . The loss of barrier function of both mitochondrial membranes is controlled, at least in part, by the permeability transition pore complex (PTPC) (Marchetti et al., 1996a; Marzo et al., 1998b) , a polyprotein complex which includes the most abundant proteins of the outer and inner mitochondrial membranes, the voltagedependent anion channel (VDAC) and the adenine nucleotide translocator (ANT), respectively (Beutner et al., 1998; Crompton et al., 1998; Marzo et al., 1998b; Wood®eld et al., 1998) . Moreover, the PTPC contains proteins from the Bcl-2/Bax family (Marzo et al., 1998b; Narita et al., 1998) , as well as soluble proteins such as the matrix protein cyclophilin D, the pharmacological target of the prototypic PTPC inhibitor cyclosporin A (CsA) (Crompton et al., 1998; Wood®eld et al., 1998) . Recent studies indicate that pro-apoptotic proteins such as Bax or Bak physically interact with ANT and/or VDAC to facilitate membrane permeabilization (Marzo et al., 1998a; Shimizu et al., 1999) , whereas antiapoptotic proteins such as Bcl-2 or Bcl-X L stabilize the barrier function of mitochondrial membranes Kluck et al., 1997; Marzo et al., 1998a,b; Narita et al., 1998; Shimizu et al., 1999; Susin et al., 1996; Yang et al., 1997; Zamzami et al., 1996) . Whether the outer membrane or the inner membrane are permeabilized ®rst during the apoptotic process is the matter of an intense, hitherto inconclusive debate (Green and Reed, 1998; Heiskanen et al., 1999; Kroemer et al., 1998) , and may well depend on the cell type and the apoptosis inducer.
Two strategies have been designed to enforce PTPC opening in spite of the presence of Bcl-2. The ®rst strategy consists in the occupation of the mitochondrial benzodiazepin receptor (Hirsch et al., 1998; Marchetti et al., 1996b) , an outer mitochondrial membrane protein which physically interacts with VDAC and ANT (McEnery et al., 1992) . Ligands of the mitochondrial benzodiazepin receptor such as PK11195 can overcome the apoptosis resistance of Bcl-2 overexpressing cells in response to diverse stimuli including glucocorticoids (Hirsch et al., 1998) , the topoisomerase inhibitor VP16 (Hirsch et al., 1998) , lonidamine (Ravagnan et al., 1999) or arsenite (Larochette et al., 1999) . The second strategy to overcome Bcl-2-mediated cytoprotection consists in the utilization of diazenedicarboxylic acid bis 5N, Ndimethylamide (diamide), a thiol crosslinking agent which enforces PTPC opening even in the presence of Bcl-2 or in the absence of Bax (Marzo et al., 1998a; Zamzami et al., 1998) . In contrast to PK11195, diamide alone suces to cause PTPC opening and apoptosis induction.
The exact target of diamide within the PTPC has been unknown. Similarly, it has been elusive whether other thiol reactive agents could mimic the eect of diamide. Here we report that diamide acts on cysteine 56 of ANT to cause its oxidation and/or derivatization and the formation of ANT dimers, culminating in opening of the PTPC. Several other thiol crosslinking agents can have a similar eect on ANT and enforce PTPC opening in the presence of Bcl-2. Thus, our data identify ANT as a major component of redox-sensitive PTPC regulation and delineate a general strategy for the design of apoptosis inducers which are insensitive to the eect of the oncoprotein Bcl-2.
Results and Discussion
Thiol crosslinking agents act on ANT to permeabilize membranes It has previously been reported that diamide added to puri®ed mitochondria can cause the formation of ANT dimers, suggesting that diamide-mediated PTPC opening might be due to its eects on ANT (Costantini et al., 1998) . To validate this hypothesis, we puri®ed ANT (495% purity) following published protocols (Marzo et al., 1998a; RuÈ ck et al., 1998) , controled by immunoblotting that the preparation was not contaminated with VDAC or cyclophilin D (Marzo et al., 1998a and data not shown), and determined whether this protein would suce to mediate a diamide response. ANT-contaning phosphatidylcholine/cardiolipin liposomes or control liposomes generated in the absence of protein were loaded with 4-methylumbelliferylphosphate disodium salt (4-MUP, 300 Da) and exposed to increasing doses of diamide. Then, alkaline phosphatase was added to convert liposome-released 4-MUP into the¯uorochrome 4-methylumbelliferone (4-MU), followed by the determination of 4-MUdependent¯uorescence. ANT liposomes, not control liposomes respond to diamide as well as to two similar thiol crosslinking agents, bis-maleimido-hexane (BMH) or dithiodipyridine (DTDP) by becoming permeable to 4-MUP (Figure 1a ). These eects were not observed when liposomes generated in the absence of ANT were exposed to these agents (not shown), thus arguing against a non-speci®c, detergent-like eect of such agents. Moreover, the membrane permeabilization eect induced by diamide was completely inhibited by addition of ADP or ATP, the two physiological ligands of ANT (Figure 1b) , thereby excluding a direct eect of diamide on lipids. In conclusion, ANT mediates membrane permeabilization induced by thiol crosslinking.
Diamide, BMH, and DTDP cause oxidation of Cys56 of ANT Diamide causes a fraction of ANT to undergo dimerization, as revealed by electrophoresis in nonreducing conditions (Costantini et al., 1998) . To improve the detection of thiol oxidation within ANT, partially puri®ed ANT preparations (*50% ANT of total protein, Figure 2a ) were exposed to thioloxidizing agents or control pro-oxidants (arsenite or Figure 1 Direct eect of diamide, BMH and DTDP on ANT. ANT was puri®ed from rat heart and reconstituted into phosphatidylcholine/cardiolipin vesicles loaded with the fluorogenic substrate 4-MUP of alkaline phosphatase. Liposomes were left untreated (control) or exposed to the indicated dose of atractyloside (Atr), diamide, BMH, and DTDP. Then, alkaline phosphatase was added to obtain the transformation of liposomereleased 4-MUP into MU, which was quantitated by¯uorometry. Results are representative of four (diamide) or two (BMH, DTDP) independent experiments (a). In one series of experiments 1 mM ADP or 10 mM ATP were added to the liposomes 40 min before treatment with atractyloside or diamide (b). Data are expressed on a scale on which 100% is de®ned as the response to the optimal dose (200 ± 300 mM) of atractyloside. Control experiments performed with liposomes generated in the absence of ANT yielded similar detergent-mediated 4-MUP release, yet yielded negative data (53% release) with thiol crosslinkers (not shown)
tert-butylhydroperoxide, t-BHP) and loaded on a phenylarsine oxide column, which retains proteins with accessible thiols (Halestrap et al., 1997) . Addition of excess dithiothreitol allows for the elution of the non-oxidized protein from the column. As shown in Figure 2b , only thiol-reactive agents such as diamide, BMH and DTDP, but neither arsenite nor t-BHP, caused oxidation of all accessible thiols of ANT, leading to a complete inhibition of ANT retention on the phenylarsine oxide column. Accordingly, all thiolreactive agents (but neither arsenite nor t-BHP) caused the formation of ANT dimers with an apparent molecular mass of *60 kDa detectable by PAGE under non-reducing conditions (Figure 2c ). To clarify which cystein is derivatized in ANT, semi-puri®ed ANT protein was incubated to N-(1-pyrenil)maleimide (PYM), an agent which becomes¯uorescent upon reaction with cysteins ( Figure 3a) . PYM is known to react speci®cally with cysteine 56 of ANT (Beyer and Nuscher, 1996) . Preincubation of ANT with diamide, BMH, and DTDP (not arsenite or t-BHP) caused the disappearance of the pyrenylmaleimide-dependent uorescent signal ( Figure 3b ). Altogether, these data indicate that diamide-like thiol reactive agents oxidize and/or derivatize cysteine 56 of ANT. This cysteine residue faces the matrix side of ANT, between the ®rst two membrane-spanning transmembrane domains of ANT (Klingenberg, 1993; Majima et al., 1995; Palmieri, 1994) . It thus constitutes a prime candidate for being identical with the oxidation-sensitive thiol of the PTPC that, based on its inaccessibility to a hydrophilic thiol crosslinker (monobromotrimethylammoniobimane), has been postulated to face the matrix side of the inner mitochondrial membrane (Costantini et al., 1995a (Costantini et al., , 1996 (Costantini et al., , 1998 .
ANT thiol oxidation in intact mitochondria and intact cells
As to be expected from the results obtained with semipuri®ed ANT (Figures 1, 2, 3) , diamide, BMH, and DTDP induce large amplitude swelling when added to puri®ed mitochondria (Figure 4 ). This eect was inhibited by the PT pore inhibitor CsA, suggesting Figure 2 Eects of diamide, BMH, DTDP, t-BHP and arsenite on thiols within the ANT. ANT was purifed from rat liver mitoplasts using the hydroxyapatite (HAP) puri®cation procedure (for details, see Materials and methods), followed by SDS ± PAGE in reducing conditions and Coomassie blue staining (a). This ANT preparation was incubated 20 min at RT in the absence (control) or presence of 100 mM diamide, 5 mM BMH, 20 mM DTDP, 20 mM t-BHP and 1 mM arsenite, then retained on a phenylarsine oxide column, eluted with 10 mM dithiothreitol, and analysed by immunoblot under reducing conditions, as described in Materials and methods (b). Alternatively, the¯ow through of the columns were separated by SDS ± PAGE under non-reducing conditions and subjected to immunodetection of ANT (c). Results are representative of three independent determinations that it indeed involves the PTPC (Figure 4) . Under these circumstances, in intact mitochondria, these agents all cause complete cysteine oxidation/derivatization of ANT, which is no more retained by the phenylarsine oxide matrix (Figure 5a ). The degree of ANT oxidation/derivatization induced by diamide, BMH and DTDP is the same as for positive controls treated with N-ethylmaleimide (NEM) or phenylarsineoxide. CsA failed to prevent the diamide eect on ANT under these circumstances (not shown). Note that under these experimental conditions, ANT but not VDAC was retained by the phenylarsine column, suggesting that VDAC possesses no accessible thiols that could be subject of modi®cation (Figure 5b) . Similarly, in intact cells, diamide causes ANT thiol oxidation/derivatization (Figure 5c ) in conditions in which it induces apoptosis. In strict contrast, the prooxidant t-BHP does not aect the thiol accessibility of ANT, neither in isolated mitochondria (Figure 5a ) nor in intact cells (Figure 5c ), even in conditions in which mitochondria undergo complete large amplitude swelling (not shown) or 498% cells have died. This clearly indicates that t-BHP does not act on ANT thiols to induce PT pore opening and apoptosis.
Failure of Bcl-2 to prevent ANT oxidation and apoptosis induction by several thiol-reactive agents Since Bcl-2 has been described as an antioxidant (Hockenbery et al., 1993; Kane et al., 1993) and can interact with ANT (Marzo et al., 1998a) , we determined whether Bcl-2 might inhibit the thiol oxidation of ANT in vitro. Addition of recombinant Bcl-2 failed to aect the degree of Cys56 labeling of ANT by PYM in vitro and did not aect the kinetics of this reaction (Figure 6a, trace b) . Thus, Bcl-2 does not mask the critical thiol of ANT. Similarly, transfectionenforced overexpression of Bcl-2 failed to prevent thiol oxidation/derivatization of ANT induced by DTDP, and BMH added to intact cells (Figure 6b ). If thiol oxidation/derivatization of ANT is apoptogenic and Bcl-2 fails to protect ANT against thiol modi®cation, then thiol oxidation of ANT should overcome the Bcl-2 mediated cytoprotection. Indeed, DTDP and BMH killed cells tranfected with the human Bcl-2 gene with the same ecacy as control cells expressing the neomycin resistance vector (Neo) only. Both agents caused a similar DC m collapse (Figure 7a ) and Rat liver mitochondria were treated with 25 mM Ca 2+ (a condition not accompanied by MTP opening under these conditions, not shown; control), or with the same amount of Ca 2+ followed by 1 mM NEM, 100 mM phenylarsine oxide, 100 mM DIA, 50 mM BMH, 20 mM DTDP, 20 mM t-BHP or 1 mM arsenite, reagents that all induced the pore opening within 10 ± 15 min (Figure 4 and data not shown). After 15 min, mitochondria were extracted with Triton X-100; the extracts were then added to a phenylarsine oxide column and the column was eluted with dithiothreitol. Samples of the¯ow-through and the ®rst eluted fraction were analysed by SDS ± PAGE under reducing conditions, followed by Western blotting with anti-ANT (a) and anti-VDAC (b) antibodies. (c) Modi®cation of ANT thiols in intact cells. 40610 6 2B4.11 Neo-cells were cultured overnight in the presence or in the absence of 100 mM DIA or 30 mM t-BHP, leading to 495% loss of viability, as determined by staining with propidium iodide. The mitochondrial proteins were then extracted and added to a phenylarsine oxide column, eluted with dithiotreitol and subjected to ANT immunodetection hypoploidy (Figure 7b ) in Bcl-2 overexpressing and control cells, although Bcl-2 conferred near-to-complete protection against glucocorticoid-induced apoptosis (Figure 7a,b) . Dose response analyses con®rmed that diamide, BMH, DTDP, and phenylarsine oxide enforce mitochondrial dysfunction in Bcl-2 expressing cells (Figure 7c ), which are well protected against other pro-oxidants including t-BHP and arsenite. Thus, thiol crosslinking agents can overcome the Bcl-2 mediated inhibition of cell death.
Concluding remarks
The results presented in this paper indicate that several thiol-crosslinking agents (diamide, BMH and DTDP) have similar eects on Cys56 of ANT, when added to cells (Figures 5c, 7) , isolated mitochondria (Figures 4,  5a) , or puri®ed ANT (Figures 1 ± 3) , correlating with their membrane permeabilizing eect. Although the eects of thiol-crosslinking agents on complex systems may involve additional eects of oxidation, our data suggest that ANT may be (one of) the criticial target molecule(s) responsible for mitochondrial membrane pemeabilization and cell death induced by such agents. It appears plausible that this Cys56 modi®cation alters the conformation of ANT inducing it to become a nonspeci®c pore, thus mimicking the eect of Ca 2+ which converts ANT into a large channel (Brustovetsky and Klingenberg, 1996) . One remarkable feature of ANT Cys56 oxidation/derivatization is that it is not inhibited by Bcl-2 (Figure 6a,b) and that it causes a type of mitochondrial permeabilization which is not antago- Bcl-2 or Neo-transfected cells were cultured overnight in the absence (control) or presence of 3 mM BMH or 30 mM DTDP. ANT was then analysed for thiol modi®cation on a phenylarsine oxide column. Column eluated were separated on SDS ± PAGE under reducing conditions and analysed by Western blotting with an antibody anti-ANT Figure 7 Failure of Bcl-2 to prevent apoptosis induced by thiol crosslinking agents. Cells stably transfected with the human bcl-2 gene or a neo control vector were cultured under the following conditions: 7 h in the presence or in the absence of DTDP or BMH, 12 h in the presence or in the absence of DIA or dexamethasone (DEX). The following apoptosis-associated parameters were then assessed: loss of the DC m , determined by the potential-sensitive dye DiOC 6 (3) (a, c), increase in the generation of hydroethidine-sensitive ROS (a) and propidium iodide (PI)-detectable loss of nuclear DNA (b). (a and b) demonstrate the eects of 30 mM DTDP, 3 mM BMH and 1 mM DEX, whereas (c) details the dose-responses obtained for the indicated apoptogenic agent nized by Bcl-2 (Figure 7) . Thus the capacity to overcome Bcl-2 mediated cytoprotection is not a speci®c property of diamide. Rather, it extends to other thiol crosslinkers acting on ANT. Since the Cys56 of ANT is located at the matrix site of the inner mitochondrial membrane, it may be possible to design positively charged thiol crosslinkers which would speci®cally enrich at this site of the inner membrane (negative charges inside), following the Nernst equation. On theoretical grounds, such positively charged yet lipophilic thiol crosslinkers would have a higher cytotoxic potential than non-charged crosslinkers. Irrespective of this possibility, the data shown here underscore the possibility that speci®c targeting of accessible thiols within the PTPC may result in the design of cytotoxic drugs which induce apoptosis irrespective of Bcl-2 expression.
Materials and methods
Cell culture and cyto¯uorimetric determination of apoptosis-associated parameters 2B4.11 T cell hybridoma cell lines stably transfected with a SFFV neo vector containing the human bcl-2 gene or the neomycin resistance gene (Neo) only were cultured in RPMI 1640 supplemented with 10% FCS, antibiotics and Lglutamine, in the presence or absence of 2,2'-dithiodipyridine (DTDP, Sigma, St Louis, MO, USA), 1,6-bismaleimidohexane (BMH, Pierce, Rockford, IL, USA), diazenedicarboxylic acid bis 5N,N-dimethylamide (diamide, Sigma), dexamethasone (DEX), phenylarsineoxide, or tert-butylhydroperoxide (t-BHP, Sigma). The following¯uorochromes were employed to assess apoptosis-associated changes (Zamzami et al., 1995) : 3,3' dihexyloxacarbocyanine iodide (DiOC 6 (3), 20 nM) for DC m quanti®cation and hydroethidine (HE, 4 mM) for the determination of superoxide anion generation. The frequency of hypoploid cells was determinated by propidium iodide (PI) staining of ethanol-permeabilized cells.
Isolation of rat liver mitochondria and measurement of MTP opening
Rat liver mitochondria from Albino Wistar rats, prepared by standard dierential centrifugation as previously described (Costantini et al., 1995b) , were suspended in 0.2 M sucrose, 10 mM Tris-MOPS, pH 7.4, 5 mM succinate-Tris, 1 mM Pi, 2 mM rotenone and 10 mM EGTA-Tris (swelling buer) at a protein concentration of 0.5 mg6 ml
71
. PT opening was monitored as the change of 908 light scattering at 545 nm using a Hitachi F-4500¯uorescence spectrophotometer.
Puri®cation of ANT and determination of ANT-faciliated membrane permeabilization ANT was puri®ed (RuÈ ck et al., 1998) from rat heart mitochondria (Susin et al., 1999a) . Mitochondria were subjected to mechanical shearing in a Elvejhem potter: solubilized (8 min, 48C) in buer A (220 mM mannitol, 70 mM sucrose, 10 mM HEPES (pH 7.4), 200 mM EDTA, 10 mM dithiothreitol) supplemented with 0.5 mg/ml subtilisin; and subjected to dierential centrifugation (5 min 500 g, discard pellet; then 10 min 10 000 g, discard supernatant). Soluble (30 min, 24 0006g, 48C) mitochondrial proteins (10 mg/ml) were resuspended in buer B (40 mM KH 2 PO 4 (pH 6.0), 40 mM KCl, 2 mM EDTA and 6% [vol:vol] Triton X-100; Boehringer Mannheim, Mannheim, Germany). This operation was repeated once. Two ml of this solution were applied to a column containing 1 g hydroxyapatite (BioGel HTP, Biorad) and eluted with buer B, then diluted 1 : 1 with buer C (20 mM MES, 200 mM EDTA, pH 6.0; 0.5% Triton X-100). This preparation was applied to a HiTrap SP column (Pharmacia Biotech, Uppsala, Sweden) pre-equilibrated with buer C, washed with buer C, and eluted at a¯ow of 1 ml/ min by gradually increasing the salt concentration (0 ± 500 mM NaCl within 10 min). ANT containing fractions were checked for purity using silver staining and immunoblot (12.5% SDS ± PAGE, 3 mg protein/lane) using a monoclonal antibody recognizing VDAC (31HL, Calbiochem), a polyclonal rabbit antisera speci®c for ANT (Giron-Calle and Schmid, 1996) , or an antiserum raised against the N-terminus of cyclophilin D (Nicolli et al., 1996) . ANT was incorporated into phosphatidylcholine/cardiolipin (1 : 45 w : w) liposomes (300 ng ANT per mg lipid) by overnight dialysis. Liposomes were loaded with 5-MUP (1 mM, Sigma) in 10 mM KCl by sonication and separated on Sephadex G25 columns (Marzo et al., 1998b) . After incubation with the indicated thiol crosslinking agent, 25 ml liposomes were diluted in 3 ml 125 mM sucrose, 1 mM MgCl 2 , 10 mM HEPES (pH 7.4), 10 mM dithiothreitol, and alkaline phosphatase (1.5 U/ml; Boehringer Mannheim, Mannheim, Germany), incubated for 5 min at 378C, supplemented with 300 ml NaOH (1 M) and 10 mM EGTA, and subjected to the¯uorometric quantitation of 5-MU (excitation 365 nm, emission 450+5 nm). In some experiments, ANT was prepared from rat liver mitoplasts (Pedersen et al., 1978) using the hydroxyapatite column without further FPLC puri®cation. These preparations (which contain *50% ANT) are referred to as`semi-puri®ed' ANT.
Binding of the ANT to phenylarsine oxide columns Semi-puri®ed ANT (100 ml, 2 mg protein/ml) or extracts of puri®ed mitochondria (2 mg protein in 4 ml swelling buer, treated with diamide, DTDP, BMH, t-BHP etc., then sedimented by centrifugation and extracted as described (Halestrap et al., 1997) ) were applied to 4-aminophenylarsine oxide columns (pAPAO agarose, Sigma) (Halestrap et al., 1997). Alternatively 40610 6 2B4.11T cells (Neo and Bcl-2) were cultured in the presence of DIA, t-BHP, DTDP or BMH, collected by centrifugation, washed twice with cold PBS, and homogenized in 0.15 mM MgCl 2 10 mM KCl, 10 mM Tris-HCl, pH 7.6. The cell lysates were centrifugated (3 min, 9006g, 48C) to remove nuclei and the supernatants were centrifugated again (10 min, 10 0006g) to recover the mitochondria-containing pellet. Each pellet was then extracted as described (Halestrap et al., 1997) before application to 4-aminophenylarsine oxide column. One hundred ml of each extracts were incubated with 50 ml of resin which had been sequentially washed twice with water and three times with a buer containing 50 mM HEPES, pH 7.2, 150 mM Na 2 SO 4 , 1 mM EDTA, 0.25% Triton X-100, and the protease inhibitors antipain, leupeptin and pepstatin at 1 mg6ml 71 (column buer). After 15 min of incubation at 48C under gentle agitation, the samples were centrifugated 10 min at 12 0006g, 48C, the supernatants (corresponding to the¯ow through) were carefully removed, and the unbound material was washed through the column with the column buer before elution with 50 ml of the same buer containing additional 10 mM dithiothreitol (Sigma). Samples (15 ml) of both¯ow through and ®rst eluted fraction were separated on 12% acrylamide-0.3% bisacrylamide gels, followed by Western blotting and immunodetection of ANT (polyclonal rabbit antiserum kindly provided by Dr Heide H Schmid, The Hormel Institute, University of Minneapolis, MI, USA; dilution 1 : 1000) or VDAC (anti-VDAC 31HC from Calbiochem; dilution 1 : 500).
Fluorescence labeling of the isolated ANT with N-(1-pyrenil)maleimide (PYM)
The experiments were performed essentially as described by (Beyer and Nuscher, 1996) . Brie¯y, 20 mg of partially puri®ed ANT were incubated under stirring in 400 ml of 100 mM NaCl, 50 mM NaN 3 and 10 mM Tris-MOPS, pH 7.2. Sulphydryl alkylation was initiated by addition of 10 ml of N-(1-pyrenyl)maleimide (0.12 mg/ml in absolute ethanol, Sigma) in the presence or abscence of NEM, BMH, DIA, DTDP, t-BHP, arsenite and recombinant Bcl-2 (puri®ed as described, Schendel, 1997, at the concentrations indicated in the ®gure legend. The¯uorescence of PYM was excited at 340 nm and the emitted light was measured at 357 nm using a Hitachi F-4500¯uorescence spectrophotometer. The excitation and emission slits were both set at 10 nm.
Abbreviations ANT, adenine nucleotide translocator; BMH, bis-maleimido-hexane, CsA, cyclosporin A; diamide, diazenedicarboxylic acid bis 5N,N-dimethylamide; DCm, mitochondrial transmembrane potential; DiOC 6 (3), 3,3'dihexyloxacarbocyanine iodide; dithiodipyridine, DTDP; HE, hydroethidine; 4-MUP, 4-methylumbelliferylphosphate; 4-MU, 4-methylumbelliferone; PI, propidium iodide; PT, permeability transition; PTPC, permeability transition pore complex; PYM, N-(1-pyrenil)maleimide; t-BHP, tert-butylhydroperoxide; VDAC, voltage dependent anion channel.
